To the Editor:The coronavirus disease , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major burden on healthcare systems and communities worldwide. It required fast response, transformation of hospitals, and a change of our habits.Many studies have found that chronic kidney disease (CKD) is a risk factor for a more severe course of COVID-19, unfavorable outcomes, with patients receiving dialysis having the highest mortality across all studied factors. [1][2][3] In addition to higher mortality, more adverse outcomes, and severe course of the disease, COVID-19 was more prevalent in patients with CKD receiving dialysis. A cross-sectional study in the United States proved that seroprevalence of SARS-CoV-2 spike protein antibodies was higher in dialysis patients compared to the general public. This demonstrates that patients on dialysis may also be the source of community spread of COVID-19. 4,5 Patients receiving in-center hemodialysis cannot isolate or pause their treatments, resulting in interrupted dialysis schedules or emergent dialysis sessions and even death. 6 With safe vaccination options becoming widely available across the world, there is no doubt that patients with end-stage renal disease (ESRD) should be among the first to be immunized. After extensive discussions, Lithuanian